Established in 2020, Newsyn Biotech Pte. Ltd. is a leading distributor of pharmaceuticals and fast-moving consumer goods (FMCG), committed to driving market access and supply chain excellence. We deliver regulatory-compliant, market-ready pharmaceutical solutions that meet the highest global standards, ensuring seamless distribution across key markets.
Beyond healthcare, we leverage strategic partnerships to expand our FMCG portfolio, bringing trusted Asian brands to international markets. As the exclusive distributor of Jinmailang Food Co., Ltd. and Hebei Jindu Food Co. in Singapore, we play a pivotal role in enhancing category growth and consumer engagement in the region.
Through supply chain optimization, market intelligence, and brand stewardship, Newsyn Biotech bridges pharmaceutical innovation and premium FMCG distribution, delivering value across diverse industries.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2 Kallang Avenue, #09-09, Ct Hub, Singapore 339407, Singapore,339407,singapore
- Industry
- Wholesale Import And Export
- Keywords
- IT Consulting.
- HQ
- Singapore
Newsyn Biotech Questions
Newsyn Biotech's LinkedIn profile is https://sg.linkedin.com/company/newsynbiotech
Newsyn Biotech has
2 employees.
View email and phone details for 2
employees at Newsyn Biotech.
Newsyn Biotech's industry is
Wholesale Import and Export
Newsyn Biotech's top competitors are
Pinnacle Biotech Pte Ltd,
Fusipim Malaysia,
(주)어떤사람들,
Future Retail Pte Ltd,
Arista Biotech Pte. Ltd.,
Simexpo International Limited,
Bd,
Digital & Ai Fintax Solutions, Singapore,
Access Asia Biotech Consultancy,
Robotcoupe.
Newsyn Biotech's categories are Wholesale Import and Export
Newsyn Biotech's founding year is 2020
